Blood Substitute Resuscitation as a Treatment Modality for Moderate Hypovolemia

Blood substitute resuscitation as a treatment modality for moderate hypovolemia (˜40% blood loss) in a canine model has been evaluated using Oxyglobin® (Biopure Hemoglobin Glutamer-200 Bovine; a hemoglobin-based oxygen-carrier) and Hespan® (6% hetastarch; a nonoxygen-carrier) as resuscitants. Autolo...

Full description

Saved in:
Bibliographic Details
Published inArtificial cells, blood substitutes, and immobilization biotechnology Vol. 32; no. 2; pp. 189 - 207
Main Authors Cheung, Anthony T. W., Driessen, Bernd, Jahr, Jonathan S., Duong, Patricia L., Ramanujam, Sahana, Chen, Peter C. Y., Gunther, Robert A.
Format Journal Article
LanguageEnglish
Published England Informa UK Ltd 01.01.2004
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Blood substitute resuscitation as a treatment modality for moderate hypovolemia (˜40% blood loss) in a canine model has been evaluated using Oxyglobin® (Biopure Hemoglobin Glutamer-200 Bovine; a hemoglobin-based oxygen-carrier) and Hespan® (6% hetastarch; a nonoxygen-carrier) as resuscitants. Autologous (shed) blood served as control. Nine dogs were studied-after splenectomy, each dog was hemorrhaged (32-36 mL kg; MAP = ˜50 mmHg) and randomly assigned to the three resuscitation groups. Microvascular, systemic function and oxygenation characteristics were monitored and or measured simultaneously in prehemorrhagic (baseline), posthemorrhagic and postresuscitation phases for correlation-real-time microvascular changes in the bulbar conjunctiva were noninvasively measured via computer-assisted intravital microscopy and systemic function and oxygenation changes were monitored and or measured via instrumentation and devices incorporated into our bioengineering station in an operating room setting. Blood chemistry was also studied for relevant measurements. Prehemorrhagic microvascular characteristics were similar in all animals (venular diameter = 41 ± 12 µm, A:V ratio = ˜1:2, red-cell velocity = 0.5 ± 0.3 mm s). All animals also showed similar prehemorrhagic systemic function and oxygenation measurements comparable to a previous study and were consistent with normal measurements in dogs. At the completion of hemorrhaging to achieve moderate hypovolemia (˜40% blood loss with MAP at ˜50 mmHg), all nine animals showed similar significant (P < 0.01) posthemorrhagic microvascular changes, including ˜17% decrease in diameter (34 ± 7 µm), A:V ratio = variable, and ˜80% increase in velocity (0.9 ± 0.5 mm s). All animals also showed similar significant (P < 0.01) posthemorrhagic systemic function and oxygenation changes, with decreases in Hct, aHbtotal, MPAP, MAP, SAP, DAP, CO, SVI, CaO2, and CvO2 and increases in HR and lactic acidosis. Shed blood (control) resuscitation restored posthemorrhagic microvascular changes close to prehemorrhagic values (diameter = 39 ± 6 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm s). Oxyglobin® and Hespan® restored microvascular changes in similar manner close to prehemorrhagic values (Oxyglobin®: diameter = 38 ± 3 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm s; Hespan®: diameter = 38 ± 7 µm, A:V ratio = ˜1:2, velocity = 0.5 ± 0.4 mm s). After resuscitation, shed blood (control) restored all systemic function and oxygenation changes close to prehemorrhagic values. However, both Oxyglobin® and Hespan® resuscitation restored systemic function changes, but not oxygenation changes, to prehemorrhagic values. This was an interesting finding because of the different oxygen-carrying capability of Oxyglobin® (oxygen-carrying) and Hespan® (nonoxygen-carrying). The result suggests that either volume replenishment alone (and not oxygen-carrying capability) is needed to treat moderate hypovolemia or oxygenation measurements obtained by standard methods (oximetry, blood chemistry) may not reflect tissue oxygenation levels.
AbstractList Blood substitute resuscitation as a treatment modality for moderate hypovolemia (˜40% blood loss) in a canine model has been evaluated using Oxyglobin® (Biopure Hemoglobin Glutamer-200/Bovine; a hemoglobin-based oxygen-carrier) and Hespan® (6% hetastarch; a nonoxygen-carrier) as resuscitants. Autologous (shed) blood served as control. Nine dogs were studied-after splenectomy, each dog was hemorrhaged (32-36 mL/kg; MAP = ˜50 mmHg) and randomly assigned to the three resuscitation groups. Microvascular, systemic function and oxygenation characteristics were monitored and/or measured simultaneously in prehemorrhagic (baseline), posthemorrhagic and postresuscitation phases for correlation-real-time microvascular changes in the bulbar conjunctiva were noninvasively measured via computer-assisted intravital microscopy and systemic function and oxygenation changes were monitored and/or measured via instrumentation and devices incorporated into our bioengineering station in an operating room setting. Blood chemistry was also studied for relevant measurements. Prehemorrhagic microvascular characteristics were similar in all animals (venular diameter = 41 ± 12 µm, A:V ratio = ˜1:2, red-cell velocity = 0.5 ± 0.3 mm/s). All animals also showed similar prehemorrhagic systemic function and oxygenation measurements comparable to a previous study and were consistent with normal measurements in dogs. At the completion of hemorrhaging to achieve moderate hypovolemia (˜40% blood loss with MAP at ˜50 mmHg), all nine animals showed similar significant (P < 0.01) posthemorrhagic microvascular changes, including ˜17% decrease in diameter (34 ± 7 µm), A:V ratio = variable, and ˜80% increase in velocity (0.9 ± 0.5 mm/s). All animals also showed similar significant (P < 0.01) posthemorrhagic systemic function and oxygenation changes, with decreases in Hct, aHb total , MPAP, MAP, SAP, DAP, CO, SVI, CaO 2 , and CvO 2 and increases in HR and lactic acidosis. Shed blood (control) resuscitation restored posthemorrhagic microvascular changes close to prehemorrhagic values (diameter = 39 ± 6 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm/s). Oxyglobin® and Hespan® restored microvascular changes in similar manner close to prehemorrhagic values (Oxyglobin®: diameter = 38 ± 3 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm/s; Hespan®: diameter = 38 ± 7 µm, A:V ratio = ˜1:2, velocity = 0.5 ± 0.4 mm/s). After resuscitation, shed blood (control) restored all systemic function and oxygenation changes close to prehemorrhagic values. However, both Oxyglobin® and Hespan® resuscitation restored systemic function changes, but not oxygenation changes, to prehemorrhagic values. This was an interesting finding because of the different oxygen-carrying capability of Oxyglobin® (oxygen-carrying) and Hespan® (nonoxygen-carrying). The result suggests that either volume replenishment alone (and not oxygen-carrying capability) is needed to treat moderate hypovolemia or oxygenation measurements obtained by standard methods (oximetry, blood chemistry) may not reflect tissue oxygenation levels.
Blood substitute resuscitation as a treatment modality for moderate hypovolemia (approximately 40% blood loss) in a canine model has been evaluated using Oxyglobin (Biopure Hemoglobin Glutamer-200/ Bovine; a hemoglobin-based oxygen-carrier) and Hespan (6% hetastarch; a nonoxygen-carrier) as resuscitants. Autologous (shed) blood served as control. Nine dogs were studied--after splenectomy, each dog was hemorrhaged (32-36 mL/kg; MAP = approximately 50 mmHg) and randomly assigned to the three resuscitation groups. Microvascular, systemic function and oxygenation characteristics were monitored and/or measured simultaneously in prehemorrhagic (baseline), posthemorrhagic and postresuscitation phases for correlation-real-time microvascular changes in the bulbar conjunctiva were noninvasively measured via computer-assisted intravital microscopy and systemic function and oxygenation changes were monitored and/or measured via instrumentation and devices incorporated into our bioengineering station in an operating room setting. Blood chemistry was also studied for relevant measurements. Prehemorrhagic microvascular characteristics were similar in all animals (venular diameter = 41 +/- 12 microm, A:V ratio = approximately 1:2, red-cell velocity = 0.5 +/- 0.3 mm/s). All animals also showed similar prehemorrhagic systemic function and oxygenation measurements comparable to a previous study and were consistent with normal measurements in dogs. At the completion of hemorrhaging to achieve moderate hypovolemia (approximately 40% blood loss with MAP at approximately 50 mmHg), all nine animals showed similar significant (P < 0.01) posthemorrhagic microvascular changes, including approximately 17% decrease in diameter (34 +/- 7 microm), A:V ratio = variable, and approximately 80% increase in velocity (0.9 +/- 0.5 mm/s). All animals also showed similar significant (P < 0.01) posthemorrhagic systemic function and oxygenation changes, with decreases in Hct, aHb(total), MPAP, MAP, SAP, DAP, CO, SVI, CaO2, and CvO2 and increases in HR and lactic acidosis. Shed blood (control) resuscitation restored posthemorrhagic microvascular changes close to prehemorrhagic values (diameter = 39 +/- 6 microm, A:V ratio = approximately 1:2, velocity = 0.6 +/- 0.4 mm/s). Oxyglobin and Hespan restored microvascular changes in similar manner close to prehemorrhagic values (Oxyglobin: diameter = 38 +/- 3 microm, A:V ratio = approximately 1:2, velocity = 0.6 +/- 0.4 mm/s; Hespan: diameter = 38 +/- 7 microm, A:V ratio = 1:2, velocity = 0.5 +/- 0.4 mm/s). After resuscitation, shed blood (control) restored all systemic function and oxygenation changes close to prehemorrhagic values. However, both Oxyglobin and Hespan resuscitation restored systemic function changes, but not oxygenation changes, to prehemorrhagic values. This was an interesting finding because of the different oxygen-carrying capability of Oxyglobin (oxygen-carrying) and Hespan (nonoxygen-carrying). The result suggests that either volume replenishment alone (and not oxygen-carrying capability) is needed to treat moderate hypovolemia or oxygenation measurements obtained by standard methods (oximetry, blood chemistry) may not reflect tissue oxygenation levels.
Blood substitute resuscitation as a treatment modality for moderate hypovolemia (˜40% blood loss) in a canine model has been evaluated using Oxyglobin® (Biopure Hemoglobin Glutamer-200 Bovine; a hemoglobin-based oxygen-carrier) and Hespan® (6% hetastarch; a nonoxygen-carrier) as resuscitants. Autologous (shed) blood served as control. Nine dogs were studied-after splenectomy, each dog was hemorrhaged (32-36 mL kg; MAP = ˜50 mmHg) and randomly assigned to the three resuscitation groups. Microvascular, systemic function and oxygenation characteristics were monitored and or measured simultaneously in prehemorrhagic (baseline), posthemorrhagic and postresuscitation phases for correlation-real-time microvascular changes in the bulbar conjunctiva were noninvasively measured via computer-assisted intravital microscopy and systemic function and oxygenation changes were monitored and or measured via instrumentation and devices incorporated into our bioengineering station in an operating room setting. Blood chemistry was also studied for relevant measurements. Prehemorrhagic microvascular characteristics were similar in all animals (venular diameter = 41 ± 12 µm, A:V ratio = ˜1:2, red-cell velocity = 0.5 ± 0.3 mm s). All animals also showed similar prehemorrhagic systemic function and oxygenation measurements comparable to a previous study and were consistent with normal measurements in dogs. At the completion of hemorrhaging to achieve moderate hypovolemia (˜40% blood loss with MAP at ˜50 mmHg), all nine animals showed similar significant (P < 0.01) posthemorrhagic microvascular changes, including ˜17% decrease in diameter (34 ± 7 µm), A:V ratio = variable, and ˜80% increase in velocity (0.9 ± 0.5 mm s). All animals also showed similar significant (P < 0.01) posthemorrhagic systemic function and oxygenation changes, with decreases in Hct, aHbtotal, MPAP, MAP, SAP, DAP, CO, SVI, CaO2, and CvO2 and increases in HR and lactic acidosis. Shed blood (control) resuscitation restored posthemorrhagic microvascular changes close to prehemorrhagic values (diameter = 39 ± 6 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm s). Oxyglobin® and Hespan® restored microvascular changes in similar manner close to prehemorrhagic values (Oxyglobin®: diameter = 38 ± 3 µm, A:V ratio = ˜1:2, velocity = 0.6 ± 0.4 mm s; Hespan®: diameter = 38 ± 7 µm, A:V ratio = ˜1:2, velocity = 0.5 ± 0.4 mm s). After resuscitation, shed blood (control) restored all systemic function and oxygenation changes close to prehemorrhagic values. However, both Oxyglobin® and Hespan® resuscitation restored systemic function changes, but not oxygenation changes, to prehemorrhagic values. This was an interesting finding because of the different oxygen-carrying capability of Oxyglobin® (oxygen-carrying) and Hespan® (nonoxygen-carrying). The result suggests that either volume replenishment alone (and not oxygen-carrying capability) is needed to treat moderate hypovolemia or oxygenation measurements obtained by standard methods (oximetry, blood chemistry) may not reflect tissue oxygenation levels.
Author Duong, Patricia L.
Driessen, Bernd
Chen, Peter C. Y.
Ramanujam, Sahana
Jahr, Jonathan S.
Cheung, Anthony T. W.
Gunther, Robert A.
Author_xml – sequence: 1
  givenname: Anthony T. W.
  surname: Cheung
  fullname: Cheung, Anthony T. W.
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 2
  givenname: Bernd
  surname: Driessen
  fullname: Driessen, Bernd
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 3
  givenname: Jonathan S.
  surname: Jahr
  fullname: Jahr, Jonathan S.
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 4
  givenname: Patricia L.
  surname: Duong
  fullname: Duong, Patricia L.
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 5
  givenname: Sahana
  surname: Ramanujam
  fullname: Ramanujam, Sahana
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 6
  givenname: Peter C. Y.
  surname: Chen
  fullname: Chen, Peter C. Y.
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
– sequence: 7
  givenname: Robert A.
  surname: Gunther
  fullname: Gunther, Robert A.
  email: atcheung@ucdavis.edu
  organization: 1Department of Medical Pathology, University of California, Davis School of Medicine, Sacramento, California, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15274428$$D View this record in MEDLINE/PubMed
BookMark eNp1kE1rFTEUhoNU7Icu3cqs3I1OPmaSu7RFbaFyQes6nCQnNCUzuSaZyv33ptyL4qKrcw4878vhOScnS1qQkLd0-EAHRT9e3mx7yoaBS8XkC3JGR856QZU4afsgeU_pZnNKzkt5GBolKHtFTunIpBBMnZHtZUzJdT9WU2qoa8XuO5a12FChhrR0UDro7jJCnXGp3bfkIIa673zKTwdmaJHr_S49pohzgNfkpYdY8M1xXpCfXz7fXV33t9uvN1efbnsr2Fh7L6hhExPKOuk4V5N0Bv1GCcn9qNBOo3GARjoBxlPBuaRoAPzAJzsaz_gFeX_o3eX0a8VS9RyKxRhhwbQWPU1SKLGRDewPoM2plIxe73KYIe81HfSTQd0M6r8GG__uWLyaGd0_-qisAeoAhKVJmOF3ytHpCvuYss-w2FA0f65b_he9R4j13kJG_ZDWvDRhz3z1B58dkyg
CitedBy_id crossref_primary_10_1080_10731190802674477
crossref_primary_10_1080_21691401_2018_1529677
crossref_primary_10_1080_10731190601188273
crossref_primary_10_1097_SHK_0000000000000687
crossref_primary_10_1111_j_1476_4431_2006_00193_x
crossref_primary_10_1016_j_resuscitation_2005_03_019
crossref_primary_10_1080_10731190601188257
crossref_primary_10_1111_j_1525_1594_2008_00693_x
crossref_primary_10_1117_1_3200932
crossref_primary_10_1097_01_shk_0000159555_87662_93
crossref_primary_10_1111_j_1467_2995_2005_00280_x
Cites_doi 10.1182/blood.V99.11.3999
10.1006/mvre.2001.2386
10.1097/00003246-199605000-00006
10.1146/annurev.med.50.1.337
10.1046/j.1365-2885.2001.00307.x
10.1097/00007890-199910150-00005
10.1097/00003246-199403000-00019
10.1046/j.1537-2995.1998.38798346630.x
10.4158/EP.7.5.358
10.1182/blood.V97.11.3401
10.3109/10731199409117408
10.1016/S1096-2867(99)80024-3
10.1097/00000539-200110000-00007
10.1093/bja/86.5.683
10.2165/00003088-199529040-00003
10.1097/01.CCM.0000063476.79749.C1
10.1080/713773960
10.1056/NEJM200006013422211
ContentType Journal Article
Copyright 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
Copyright_xml – notice: 2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1081/BIO-120037827
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Engineering
EISSN 1532-4184
EndPage 207
ExternalDocumentID 10_1081_BIO_120037827
15274428
11116894
Genre Original
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: HL67432
GroupedDBID ---
.GJ
00X
23N
36B
4.4
53G
5GY
5RE
5VS
AALIY
AALUX
AAPXX
ABDBF
ABJNI
ABUPF
ACGEJ
ACGFS
ADCVX
ADXPE
AFKVX
AI.
AIJEM
AIRBT
AJWEG
ALMA_UNASSIGNED_HOLDINGS
ARJSQ
B0M
BABNJ
BLEHA
BRMBE
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DRXRE
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
KTTOD
M44
M4Z
ML0
P2P
QQXMO
QZIEQ
SV3
TFL
TFW
TUS
V1S
VH1
ZXP
~8M
ABBKH
ABPTK
ADFCX
AEYQI
ALIIL
H13
OK1
CGR
CUY
CVF
ECM
EIF
NPM
TDBHL
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c425t-f41b26248cd7d33867dbef98473f58ec65bdaeb7d4abf143371ebaaf036c5bf23
ISSN 1073-1199
IngestDate Fri Aug 16 06:18:03 EDT 2024
Fri Aug 23 00:47:40 EDT 2024
Sat Sep 28 07:40:43 EDT 2024
Tue Jun 13 19:30:12 EDT 2023
Sun May 05 03:27:15 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c425t-f41b26248cd7d33867dbef98473f58ec65bdaeb7d4abf143371ebaaf036c5bf23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.1081/BIO-120037827?needAccess=true
PMID 15274428
PQID 66748497
PQPubID 23479
PageCount 19
ParticipantIDs proquest_miscellaneous_66748497
crossref_primary_10_1081_BIO_120037827
informahealthcare_journals_10_1081_BIO_120037827
pubmed_primary_15274428
informaworld_taylorfrancis_310_1081_BIO_120037827
PublicationCentury 2000
PublicationDate 2004-01-01
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – month: 01
  year: 2004
  text: 2004-01-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Artificial cells, blood substitutes, and immobilization biotechnology
PublicationTitleAlternate Artif Cells Blood Substit Immobil Biotechnol
PublicationYear 2004
Publisher Informa UK Ltd
Taylor & Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
References Cheung A. T. W. (CIT0006) 2002; 63
Cheung A. T. W. (CIT0003) 2001; 97
Lemmens H. J. M (CIT0016) 1995; 29
Klein H. G (CIT0015) 2000; 342
Cheung A. T. W. (CIT0005) 1999; 68
Cheung A. T. W. (CIT0007) 2001; 7
Cheung A. T. W. (CIT0002) 2002; 99
Cheung A. T. W. (CIT0004) 2001; 93
Intaglietta M (CIT0013) 1999; 6
Cheung A. T. W. (CIT0001) 2003
Driessen B. (CIT0010) 2001; 24
Driessen B. (CIT0009) 2001; 86
Hughes C. S. (CIT0011) 1996; 24
Klein H. G (CIT0014) 1995; 22
Wallace E. L. (CIT0018) 1998; 38
Winslow R. M (CIT0019) 1999; 50
Driessen B. (CIT0008) 2003; 31
Ilkiw J. E (CIT0012) 1999; 114
Rabinirici R. (CIT0017) 1994; 22
References_xml – volume: 99
  start-page: 3999
  year: 2002
  ident: CIT0002
  publication-title: Blood
  doi: 10.1182/blood.V99.11.3999
  contributor:
    fullname: Cheung A. T. W.
– year: 2003
  ident: CIT0001
  publication-title: Blood
  contributor:
    fullname: Cheung A. T. W.
– volume: 63
  start-page: 252
  year: 2002
  ident: CIT0006
  publication-title: Microvas. Res.
  doi: 10.1006/mvre.2001.2386
  contributor:
    fullname: Cheung A. T. W.
– volume: 24
  start-page: 756
  year: 1996
  ident: CIT0011
  publication-title: Crit. Care Med.
  doi: 10.1097/00003246-199605000-00006
  contributor:
    fullname: Hughes C. S.
– volume: 50
  start-page: 337
  year: 1999
  ident: CIT0019
  publication-title: Ann. Rev. Med.
  doi: 10.1146/annurev.med.50.1.337
  contributor:
    fullname: Winslow R. M
– volume: 24
  start-page: 61
  year: 2001
  ident: CIT0010
  publication-title: J. Vet. Pharmacol. Therap.
  doi: 10.1046/j.1365-2885.2001.00307.x
  contributor:
    fullname: Driessen B.
– volume: 68
  start-page: 927
  year: 1999
  ident: CIT0005
  publication-title: Transpl.
  doi: 10.1097/00007890-199910150-00005
  contributor:
    fullname: Cheung A. T. W.
– volume: 22
  start-page: 480
  year: 1994
  ident: CIT0017
  publication-title: Crit. Care Med.
  doi: 10.1097/00003246-199403000-00019
  contributor:
    fullname: Rabinirici R.
– volume: 38
  start-page: 625
  year: 1998
  ident: CIT0018
  publication-title: Transfus.
  doi: 10.1046/j.1537-2995.1998.38798346630.x
  contributor:
    fullname: Wallace E. L.
– volume: 7
  start-page: 358
  year: 2001
  ident: CIT0007
  publication-title: Endocrine Prac.
  doi: 10.4158/EP.7.5.358
  contributor:
    fullname: Cheung A. T. W.
– volume: 97
  start-page: 3401
  year: 2001
  ident: CIT0003
  publication-title: Blood
  doi: 10.1182/blood.V97.11.3401
  contributor:
    fullname: Cheung A. T. W.
– volume: 22
  start-page: 123
  year: 1995
  ident: CIT0014
  publication-title: Art. Cell Blood Substit. Immobil. Biotech.
  doi: 10.3109/10731199409117408
  contributor:
    fullname: Klein H. G
– volume: 114
  start-page: 27
  year: 1999
  ident: CIT0012
  publication-title: Clin. Techniq. in Small Animal Prac.
  doi: 10.1016/S1096-2867(99)80024-3
  contributor:
    fullname: Ilkiw J. E
– volume: 93
  start-page: 832
  year: 2001
  ident: CIT0004
  publication-title: Anesth. Analges.
  doi: 10.1097/00000539-200110000-00007
  contributor:
    fullname: Cheung A. T. W.
– volume: 86
  start-page: 683
  year: 2001
  ident: CIT0009
  publication-title: Brit. J. Anaesth.
  doi: 10.1093/bja/86.5.683
  contributor:
    fullname: Driessen B.
– volume: 29
  start-page: 231
  year: 1995
  ident: CIT0016
  publication-title: Clin. Pharmacol.
  doi: 10.2165/00003088-199529040-00003
  contributor:
    fullname: Lemmens H. J. M
– volume: 31
  start-page: 1771
  year: 2003
  ident: CIT0008
  publication-title: Crit. Care Med.
  doi: 10.1097/01.CCM.0000063476.79749.C1
  contributor:
    fullname: Driessen B.
– volume: 6
  start-page: 247
  year: 1999
  ident: CIT0013
  publication-title: Microcir.
  doi: 10.1080/713773960
  contributor:
    fullname: Intaglietta M
– volume: 342
  start-page: 838
  year: 2000
  ident: CIT0015
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM200006013422211
  contributor:
    fullname: Klein H. G
SSID ssj0003412
Score 1.39014
Snippet Blood substitute resuscitation as a treatment modality for moderate hypovolemia (˜40% blood loss) in a canine model has been evaluated using Oxyglobin®...
Blood substitute resuscitation as a treatment modality for moderate hypovolemia (approximately 40% blood loss) in a canine model has been evaluated using...
SourceID proquest
crossref
pubmed
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 189
SubjectTerms Animals
Blood Substitutes - pharmacology
Blood Substitutes - therapeutic use
Conjunctiva - cytology
Conjunctiva - drug effects
Dogs
Female
Hemodynamics - drug effects
Hemoglobins
Hemorrhage - etiology
Hemorrhage - metabolism
Hydroxyethyl Starch Derivatives - pharmacology
Hydroxyethyl Starch Derivatives - therapeutic use
Hypovolemia - drug therapy
Hypovolemia - metabolism
Male
Microcirculation - cytology
Microcirculation - drug effects
Models, Animal
Oxygen Consumption - drug effects
Title Blood Substitute Resuscitation as a Treatment Modality for Moderate Hypovolemia
URI https://www.tandfonline.com/doi/abs/10.1081/BIO-120037827
https://www.ncbi.nlm.nih.gov/pubmed/15274428
https://search.proquest.com/docview/66748497
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZKV0JwQMvyWp4-IC5RyjpxHOfYLqwqRFkJumJvkZ04ag-0qyY97P4r_iHjR9x0SyXYS1RFTeJ6vsx8nn6eQeh9pQt8xEyEkUhZSEmpQsliETKeyPhESMXMJrHJNza-oF8uk8te73dHtbRu5KC4-eu-krtYFc6BXfUu2f-wrL8pnIDPYF84goXh-E82HmnVuXn33R_-31W9hpjmFISiDkQw9UryybK0pFsrC00PNOCZwfj6agkuSv2aiy5RHa6MiEjn03Vu31jbiNyD2j-ubqWfc_jJWmRrt3QGcr5sdjL2pzPl_IqrVxBMB8HPgSfSesnuskEjtVqUXtojZqtumj_4sblm7fTEts_AXARfB1tZDHorizHdaSjS8cnghUJCbB-lgWr9dATIst3lWke-SZT69bT1yoRnnQAf2Ta7O7EDyJEpvXoeEq3YA-qUboKkly7qEMN4Ru-hgyjNkqSPDoajT6MzH_6BFjihqx21K-wKd_-4de8tInToyuTOvOjvVunc_QsgQ4Smh-iRW8HgoYXjY9RTiyP0sFPX8gjdnzjFxhN0bjCKNxjFWxjFosYCe4ziFqMYxoRbjOIORp-ii7PP09Nx6Jp4hAWEgyasKJERiygvyrSMY87SUqoqA1IUVwlXBUtkKZRMSypkBeQ9TomSQlTArIpEVlH8DPUXy4V6gbDI0ioRJOW0EjQTUnDFiyKOCBOwyo_oMfrQzmh-ZWu15EZjwUkOU5_7qT9GJzvznbv3ut53CemaI28MYCuL1Tzec8271mY5OG39toqFWq7rnOkWPzSDbzy3ptyMN9ElOyP-8g7Pe4Ue2AShFpO_Rv1mtVZvgDI38q0D6R8hAcMt
link.rule.ids 315,786,790,27955,27956
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Blood+Substitute+Resuscitation+as+a+Treatment+Modality+for+Moderate+Hypovolemia&rft.jtitle=Artificial+cells%2C+blood+substitutes%2C+and+immobilization+biotechnology&rft.au=Cheung%2C+Anthony+T.+W.&rft.au=Driessen%2C+Bernd&rft.au=Jahr%2C+Jonathan+S.&rft.au=Duong%2C+Patricia+L.&rft.date=2004-01-01&rft.pub=Taylor+%26+Francis&rft.issn=1073-1199&rft.eissn=1532-4184&rft.volume=32&rft.issue=2&rft.spage=189&rft.epage=207&rft_id=info:doi/10.1081%2FBIO-120037827&rft.externalDocID=11116894
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-1199&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-1199&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-1199&client=summon